United States · FDA National Drug Code directory
AVLAYAH
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 84976-001_352edb2c-39aa-4955-b456-f5c731b746d0
- Product NDC
- 84976-001
- Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Composition / generic term
- tividenofusp alfa-eknm
- Labeler
- Denali Therapeutics Inc.
- Marketing category
- BLA
- Marketing start / end (source format)
- 20260406
- Source listing expiry
- 20271231
Source-listed ingredients
- TIVIDENOFUSP ALFA — 150 mg/5mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL in 1 CARTON (84976-001-01) / 5 mL in 1 VIAL · 84976-001-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →